Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Edgewise Therapeutics Inc (EWTX-Q) from The Globe and Mail including charting and trades.

Corcept Therapeutics Incorporated (NASDAQ:CORT)’s total shareholder return has soared 425.83% over five years, far outpacing the US Pharmaceuticals sector. With a growing clinical team and ...

Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning. Summit has been a tremendous winner over the past ...

Consequently, RNAi therapeutics as a drug class have the potential to exert a transformational effect on modern medicine. In RNAi, the target mRNA is enzymatically cleaved, leading to decreased ...

Summit Therapeutics released more data from another HARMONi phase 3 trial. Results were "mixed," which perhaps led to some disappointment in this stock, which had rocketed higher over the past year.

Also Read: Analyst Initiates Coverage On ‘Undervalued’ Summit Therapeutics Ivonescimab, in combination with chemotherapy, showed a positive trend in OS in the primary analysis but did not ...

Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), currently trading at $0.58 with a market capitalization of $33.37 million, disclosed the results of its annual meeting of stockholders held on May 28, ...